Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 4,681,669 | 4,703,049 | 4,640,855 | 4,325,755 | 4,247,855 |
| Cost of Goods | 2,114,919 | 2,068,722 | 2,073,422 | 1,799,321 | 1,928,796 |
| Gross Profit | 2,566,750 | 2,634,327 | 2,567,433 | 2,526,435 | 2,319,059 |
| Operating Expenses | 1,545,133 | 1,838,591 | 1,617,715 | 1,582,427 | 1,499,080 |
| Operating Income | 1,022,536 | 796,458 | 950,140 | 944,328 | 820,775 |
| Interest Expense | 36,706 | 34,896 | 35,441 | 34,391 | 36,266 |
| Other Income | 80,228 | 114,110 | 113,527 | 172,868 | 144,425 |
| Pre-tax Income | 1,066,058 | 875,672 | 1,028,226 | 1,082,805 | 928,934 |
| Income Tax | 261,979 | 240,794 | 265,951 | 255,679 | 231,459 |
| Net Income Continuous | 804,079 | 634,878 | 762,275 | 827,126 | 697,475 |
| Net Income Discontinuous | N/A | -620 | 60,634 | 117,266 | 63,742 |
| Net Income | $804,079 | $634,258 | $822,909 | $944,392 | $761,217 |
| EPS Basic Total Ops | 0.52 | 0.41 | 0.53 | 0.60 | 0.49 |
| EPS Basic Continuous Ops | 0.52 | 0.41 | 0.49 | 0.53 | 0.45 |
| EPS Basic Discontinuous Ops | N/A | 0.00 | 0.04 | 0.07 | 0.04 |
| EPS Diluted Total Ops | 0.51 | 0.40 | 0.52 | 0.60 | 0.48 |
| EPS Diluted Continuous Ops | 0.51 | 0.40 | 0.48 | 0.53 | 0.44 |
| EPS Diluted Discontinuous Ops | N/A | 0.00 | 0.04 | 0.07 | 0.04 |
| EBITDA(a) | $1,335,339 | $1,149,700 | $1,239,435 | $1,270,869 | $1,058,432 |